Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e41651508566f0385833e1ba14a21ffd |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2531-119 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2565-537 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6846 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P19-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6869 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6874 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6806 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6834 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-46 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 |
filingDate |
2012-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6b32eae9ba6aff1ff128bc5598e3b5c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b27a099bb130289941d3ca90693033c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_309ecd90983baf36ab7c868efb98a677 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0fd1d4931bb8928b8d29d0cd00c69fed |
publicationDate |
2015-01-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2015031026-A1 |
titleOfInvention |
Enhanced ligation reactions |
abstract |
In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of at least one agent that generates a ligatable terminal 5′ phosphate group by removing an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, an aprataxin enzyme can catalyze removal of an adenylate group from a terminal 5′ phosphate of a nucleic acid. In some embodiments, methods for ligating nucleic acid ends comprise: conducting a nucleic acid ligation reaction in the presence of an aprataxin enzyme under conditions suitable for ligating nucleic acid ends. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11124789-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10626390-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3848457-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017139260-A1 |
priorityDate |
2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |